patients with urinary tract infection and distended bladder

Similar documents
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Molecular Imaging and the Brain

Molecular Imaging and Cancer

FDG-PET Findings in an Ovarian Endometrioma: A Case Report

POSITRON EMISSION TOMOGRAPHY (PET)

Base Phosphaturic Mesenchymal Tumor causing paraneoplastic oncogenic osteomalacia: a potential therapeutic application of PRRT beyond NET.

Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review

FDG-PET/CT for cancer management

Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography / computed tomography in fever of unknown origin

General Nuclear Medicine

Molecular Imaging and Breast Cancer

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

PET imaging of cancer metabolism is commonly performed with F18

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1

The Use of PET Scanning in Urologic Oncology

Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy

Nuclear Medicine in Thyroid Cancer. Phillip J. Koo, MD Division Chief of Diagnostic Imaging

Computed Tomography Of The Kidneys And Adrenals (Contemporary Issues In Computed Tomography)

Positron Emission Tomography in Lung Cancer

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Utilizing and Interpreting FDG-PET/CT Images in Patients Referred for Assessment of

Imaging features of malignant transformation and benign malignant-mimicking lesions in the genitourinary tracts

Sectional Anatomy Quiz - III

Imaging of Pulmonary Tuberculosis with 18 F-Fluoro-Deoxy-Glucose and

Testicular relapse of non-hodgkin Lymphoma noted on FDG-PET

A New Method for Detecting Urinary Bladder Cancer by Using FDG PET/CT

PET/CT FDG Scan for Patients with Diabetes

Title. CitationJournal of Nuclear Cardiology, 23(3): Issue Date Doc URL. Rights. Type. File Information

FDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer.

Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors

Staging recurrent ovarian cancer with 18 FDG PET/CT

Phillip J. Koo, MD Division Chief of Diagnostic Imaging Banner MD Anderson Cancer Center, USA

New Visions in PET: Surgical Decision Making and PET/CT

Brain Tumors. What is a brain tumor?

PROFESSIONAL SKILLS 1 3RD YEAR SEMESTER 6 RADIOGRAPHY. THE URINARY SYSTEM Uz. Fatema shmus aldeen Tel

Impact of fasting on 18 F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer

Small Pulmonary Nodules: Our Preliminary Experience in Volumetric Analysis of Doubling Times

Austin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir)

ONCOLOGY LETTERS 10: , 2015

WHAT DOES PET IMAGING ADD TO CONVENTIONAL STAGING OF HEAD AND NECK CANCER PATIENTS?

Pott s kyphosis. University Affiliated Sixth People s Hospital, 600 Yishan Road, Shanghai , P.

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Staging of Prostatic Carcinoma - The evolving use of SPECT-CT and Positron Emission Tomography (PET)

Positron Emission Tomography - Computed Tomography (PET/CT)

F-2-fluoro-2-deoxyglucose uptake in or adjacent to blood vessel walls

Sectional Anatomy Quiz II

Esophageal Cancer. What is esophageal cancer?

Computed Tomography of Normal Adrenal Glands in Indian Population

Diagnosis and classification

Scintillations. spect lab. A group of donkeys led by a lion can defeat a group of lions led by a donkey - Socrates. nuclear medicine services

Abnormally increased uptake of 18F-FDG in the forearm and hand following intra-arterial injection hot forearm and hot hand signs

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital

Pleural effusion as an initial manifestation in a patient with primary pulmonary monoclonal B-cell lymphocyte proliferative disease

Pancreatic Cancer. What is pancreatic cancer?

Positron Emission Tomography Computed Tomography (PET/CT)

Colorectal Cancer and FDG PET/CT

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Is ascites a sensible predictive sign of peritoneal involvement in patients with ovarian carcinoma?: our experience with FDG-PET/CT

Imaging Core Laboratory Standard Operating Procedure

F NaF PET/CT in the Evaluation of Skeletal Malignancy

FDG-PET value in deep endometriosis

Certification Review. Module 28. Medical Coding. Radiology

MC 1 Pyrexia of unknown origin

Imaging Features of Sarcoidosis on MDCT, FDG PET, and PET/CT

Indications of PET/CT in oncology

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Children's (Pediatric) Nuclear Medicine

Dual-time-point FDG-PET/CT Imaging of Temporal Bone Chondroblastoma: A Report of Two Cases

Symptoms, Diagnosis and Classification

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer

Acute renal colic Radiological investigation in patients with renal colic

PET FDG *** (cost-effectiveness) FDG-PET (fluorodeoxyglucose-positron emission tomography) PET PET PET/PET-CT PET PET FDG PET FDG PET PET PET

Genitourinary Imaging Pictorial Essay

INDICATIONS AND USAGE

Mathieu Hatt, Dimitris Visvikis. To cite this version: HAL Id: inserm

Clinical indications for positron emission tomography

Triage of Limited Versus Extensive Disease on 18 F-FDG PET/CT Scan in Small Cell lung Cancer

Novel Imaging in Advanced Prostate Cancer

Pitfalls in Oncologic Diagnosis with PET CT. Nononcologic Hypermetabolic Findings

Research Article The Advantage of PET and CT Integration in Examination of Lung Tumors

Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center

STRADA DEGLI ALBERONI 11// TURIN ITALY. Full time employee as a freelancer contract since

Thoracic Diagnostic Assessment Program. Patient information for. Last revised: November

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

PET CT for Staging Lung Cancer

Adam J. Hansen, MD UHC Thoracic Surgery

to lymph nodes of the neck

Subject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh

The role of PET/CT imaging in penile cancer

PET in Prostate Cancer

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Monophasic Synovial Carcinoma of knee joint- A Case Report and Review of Literature

APPROPRIATE USE GUIDELINES

The Diagnostic Value of PET/CT in Breast Cancer Recurrence and Metastases

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer

Transcription:

J of Nuclear Medicine Technology, first published online December 23, 2014 as doi:10.2967/jnmt.114.148031 Interesting layering of excreted 18 F-FDG in the urinary bladder in patients with urinary tract infection and distended bladder Authors:Guohua Shen, MD, a# Wenjie Zhang, MD, a Zhiyun Jia, PhD, a Houfu Deng, MD a Author Affiliations and addresses: a Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan (610041), People s Republic of China. Corresponding author or reprints contact: Dr. Zhiyun Jia Department of Nuclear Medicine, West China Hospital, Sichuan University No. 37 Guo Xue Xiang, Chengdu (610041), China Tel: +86-18980605783, Fax: + 86 28 85423503, Email: zhiyunjia@hotmail.com # First author Guohua Shen, Department of Nuclear Medicine, West China Hospital, Sichuan University. No. 37 Guo Xue Xiang, Chengdu (610041), China. Tel: +86-13980925001, Fax: +86-2885422155, Email: 1017412478@qq.com Financial Support: This study was supported by National Natural Science Foundation of China (Grant No. 81271532, 81171456 and 30900378). 1

Abstract Settlement of fluorine-18 fluorodeoxyglucose ( 18 F-FDG) in the bladder is often noted in whole-body PET/CT images, but this phenomenon never received any careful attention and the mechanism was unclear. These two patients, including one with T1 pathological fracture and the other with widespread bone and lymph node metastases from an unknown primary tumor, underwent the PET/CT examination. They both had urinary tract infection and a distended bladder during scanning. The interesting layering of 18 F-FDG in the urinary bladder was shown in both patients. Presence of this phenomenon demands careful evaluation of the urine by the clinician, and the mechanism is hypothesized to be because of slow 18 F-FDG excretion in patients with a distended urinary bladder resulting in delayed mixing with urine. In addition, urinary tract infection may be a potential cause. The clinician should pay more attention to interpreting the imaging of bladder with interesting layering. Keywords: 18 F-FDG layering; positron emission tomography/computed tomography; urinary bladder 2

Introduction Accumulation of 18 F-FDG in the urinary bladder usually makes the evaluation of bladder lesions on PET/CT difficult. At our institution, urinary bladder activity is minimized by asking the patient to drink at least 500 ml of plain water and to void before image acquisition. However, the settlement of 18 F-FDG in the urinary bladder is occasionally observed, which could impose an interpretation challenge, obscuring or simulating pathology (1). A recent study about intravenous contrast PET/CT stated that the higher specific gravity of the contrast material displaces the excreted 18 F-FDG, resulting in anterior layering of the radiotracer (2). We report herein 2 patients with bladder layering of excreted 18 F-FDG on PET/CT without intravenous contrast, and hypothesized that the phenomenon was mainly due to the delayed mixing of 18 F-FDG excretion with nonradioactive urine in a distended bladder and the urinary tract infection; however, the mechanism needs to be further investigated in a more comprehensive study. Case report The first patient was a 63-year-old woman with neck and back pain and lower limbs weakness. She has undergone PET/CT examination, and the images showed that a pathological fracture in the first thoracic vertebrae. Occasionally, there was interesting layering of excreted 18 F-FDG in the urinary bladder, showing 18 F-FDG-loaded urine at the bottom of a distended bladder and clear urine at the top (Figure 1A). The combination of radiologic images and clinical examinations revealed no bladder abnormalities but indicated a urinary tract infection. The second patient, who was 67 years old and male 3

with fever of unknown origin, was diagnosed with widespread bone and lymph node metastases from an unknown primary tumor. In addition, he had a symptom of lung infection. A clear demarcation between the urine without 18 F-FDG on the top in the bladder and 18 F-FDG-loaded urine at the bottom is also shown (Figure 1B). We noted that the urinary bladder was full during scanning. All these two patients had clear symptoms of urinary tract infection and the urine examination revealed that the urine was cloudy with elevated cell counts, red blood cell counts, white blood cell counts, and total protein content. Urine analysis was also positive for bacteria and fungus. The relevant features are summarized in Table 1 Discussion Several examples of urinary bladder layering have been reported (3-5). Carrington, BM et al described a characteristic appearance on computed tomography (CT), with urine that contains contrast medium and has a high specific gravity layering posteriorly in the dependent portion of the bladder, while lower specific gravity, non-opacified urine is found uppermost (3). Another study showed that anterior layering of excreted FDG in the bladder is commonly observed on PET/CT scans obtained with IV iodinated contrast material and is due to displacement of 18 F-FDG by excreted iodinated contrast material with higher specific gravity (5). However, these two patients in our study did not undergo CT or MRI examinations before the PET/CT evaluation, and the urine did not contain contrast medium. As mentioned above, they all had urinary tract infections, and this might be a potential cause 4

of the layering phenomenon. The metabolically active cellular component of the urine such as inflammatory cells, bacteria, and fungus uptakes the excreted 18 F-FDG in the urine for their metabolism, and these cells settle to the bottom of the bladder because of gravity during PET scanning when a patient lies supine for some time (4). Some patients did not empty the bladder before the scanning and the bladder already had a considerable amount of urine with metabolically active cells, which subsequently received 18 F-FDG-loaded urine during scanning. In addition, we also found that their urinary bladders were full during scanning, which indicated that bladder layering was associated with a distended bladder. In a distended bladder, delayed mixing of 18 F-FDG excretion with nonradioactive urine served as a cause of the layering. Moreover, PET/CT images of patients with empty urinary bladder may also help in further answering this phenomenon, whereas the settlement sign seems to be better visualized in a full bladder. To the best of authors understanding, there was no standard explanation or reason for the settlement of 18 F-FDG in the urinary bladder, which may alert the clinicians to interpret the lesions of the bladder or near the bladder more carefully. We may infer that urinary tract infection and a distended bladder are capable of inducing urinary bladder layering; however, one hundred percent cause and effect relationship could not be established because of the limited number of cases and limited information. A definitive explanation needs to be further investigated with a larger prospective study involving the systematical analysis of urine examination, bladder volume, bladder pressure, and specific gravity in patients with layering compared with those without layering. 5

In conclusion, these two cases illustrate the interesting layering of 18 F-FDG in the bladder, the causes of which might be urinary tract infection and a distended bladder; however, the mechanism needs to be further investigated in a more comprehensive study. Moreover, the presence of the settlement of 18 F-FDG in the urinary bladder should be reported with the aim to alert the clinicians to look at the urine more carefully. All shades of clinical presentations are possible. Conflicts of interest The authors declare no conflict of interest. Acknowledgements This study was supported by National Natural Science Foundation (Grant Nos., 81271532, 81171456 and 30900378). 6

References 1. Subhas N, Patel PV, Pannu HK,et al. Imaging of Pelvic Malignancies with In-Line FDG PET CT: Case Examples and Common Pitfalls of FDG PET1. Radiographics. 2005;25:1031-1043. 2. Purcell DD, Coakley FV, Franc BL, et al. Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause. AJR Am J Roentgenol. 2007;189:W96-99. 3. Duvoisin B, Fournier D. Inverted layering of contrast material and urine in the bladder on CT: sonographic correlation. AJR Am J Roentgenol. 1990;155:1139. 4. Kumar K. Settlement of [18F]-FDG in the urinary bladder-a new sign. Nucl Med Commun. 2009;30:37-40. 5. Samii VF. Inverted contrast medium-urine layering in the canine urinary bladder on computed tomography. Vet Radiol Ultrasound. 2005;46:502-505. 7

Figure Legends Figure 1. Images of computerized tomography (CT) (top), positron emission tomography (PET) (middle), and fused PET/CT (bottom) with layering of 18 F-FDG in the bladder. (A) A 63-year-old female with T1 pathological fracture and urinary tract infection, (B) A 67-year-old man with widespread bone and lymph node metastases from an unknown primary tumor, also with urinary tract infection. 8

Table 1. Clinical and pathological details of these two patients Age/Sex Diagnosis Urine examination UTI HIV status Other site of infection Patient on antibiotics 1 63/F T1 pathological fracture+uti Turbid/Cloudy, + - - + Protein>300mg/dl, Specific gravity<1.01, WBC/HP>5, RBC/HP>3, bacteria/ul>230 2 67/M widespread bone and lymph node metastases from an unknown primary tumor+uti Turbid/Cloudy, WBC/HP>5, RBC/HP>3, bacteria/ul>230 + - Pulmonary infection + F: female; M: male; T1: the first thoracic vertebrae; UTI: urinary tract infection; HIV: human immunodeficiency; +: present; -: absent; WBC: white blood cell; RBC: red blood cell; Downloaded from tech.snmjournals.org by on June 29, 2018. For personal use only. 9

Interesting layering of excreted 18 F-FDG in the urinary bladder in patients with urinary tract infection and distended bladder Guohua Shen, Wenjie Zhang, Zhiyun Jia and Houfu Deng J. Nucl. Med. Technol. Published online: December 23, 2014. Doi: 10.2967/jnmt.114.148031 This article and updated information are available at: http://tech.snmjournals.org/content/early/2014/12/23/jnmt.114.148031 Information about reproducing figures, tables, or other portions of this article can be found online at: http://tech.snmjournals.org/site/misc/permission.xhtml Information about subscriptions to JNMT can be found at: http://tech.snmjournals.org/site/subscriptions/online.xhtml JNMT ahead of print articles have been peer reviewed and accepted for publication in JNMT. They have not been copyedited, nor have they appeared in a print or online issue of the journal. Once the accepted manuscripts appear in the JNMT ahead of print area, they will be prepared for print and online publication, which includes copyediting, typesetting, proofreading, and author review. This process may lead to differences between the accepted version of the manuscript and the final, published version. Journal of Nuclear Medicine Technology is published quarterly. SNMMI Society of Nuclear Medicine and Molecular Imaging 1850 Samuel Morse Drive, Reston, VA 20190. (Print ISSN: 0091-4916, Online ISSN: 1535-5675) Copyright 2014 SNMMI; all rights reserved.